72F fusion protein vaccine
From Infogalactic: the planetary knowledge core
(Redirected from 72F fusion protein)
72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
See also
References
- Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This immunology article is a stub. You can help Wikipedia by expanding it. |
